AVT Natural Products Shares Jump 6% as Q4 PAT Surges 59% to Rs 19.29 Crore on Revenue Growth of 31%

The Quick Take

• AVT Natural Products shares rose approximately 6% after the Chennai-based plant-based extracts manufacturer reported Q4 FY2026 PAT of Rs 19.29 crore, a 59% jump year-on-year
• Standalone revenue grew 31% year-on-year, marking the company's strongest annual performance in recent years driven by demand for natural extracts across food, beverage, and nutraceutical segments
• The FY2026 full-year results showed PAT growth of approximately 41.5%, reflecting sustained momentum in AVT's high-margin specialty extracts business

AVT Natural Products' 59% PAT growth and 31% revenue growth in Q4 FY2026 is a strong earnings beat that validates the company's positioning in the high-value plant-based extracts segment. The company manufactures specialty ingredients including marigold-derived lutein, natural colours, and spice extracts — niche products where India's agricultural raw material advantage translates into global export competitiveness.

For investors in India's specialty chemicals and agri-processing sector, AVT Natural's results signal that mid-cap processors with differentiated product portfolios and export focus are benefiting from both volume growth and margin expansion as they shift toward higher-value applications. Global demand for natural colours and nutraceutical ingredients from the food and beverage industry is a structural growth driver.

Watch AVT Natural's Q1 FY2027 results and any new customer wins in regulated export markets (US, EU, Japan) — international expansion into high-margin regulated markets is the key re-rating thesis. Marigold flower procurement costs and the USD/INR exchange rate are the primary input and revenue drivers respectively for this export-oriented business.

Synthesized from 1 source.